QUEST DIAGNOSTICS INC shareholders Q2 2023

QUEST DIAGNOSTICS INC's ticker is DGX and the CUSIP is 74834L100. A total of 804 filers reported holding QUEST DIAGNOSTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

QUEST DIAGNOSTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atwater Malick LLC 52,092$7,322,1173.13%
Financial Advantage, Inc. 21,496$3,021,4782.70%
Virtus Family Office LLC 10,065$1,414,7362.62%
JGP Wealth Management, LLC 105,415$14,817,1102.42%
Galvin, Gaustad & Stein, LLC 162,030$22,774,8712.21%
DELTA CAPITAL MANAGEMENT LLC 21,415$3,0102.07%
UNITED BANK 97,364$13,685,4751.68%
Olstein Capital Management, L.P. 66,000$9,2771.50%
Aquila Investment Management LLC 13,000$1,827,2801.49%
MEMBERS CAPITAL ADVISORS INC 10,148$1,426,4031.46%
HUDSON EDGE INVESTMENT PARTNERS INC. 29,151$4,0971.30%
DAVIS SELECTED ADVISERS 1,513,888$212,792,1071.30%
Aurora Investment Counsel 14,180$1,993,1411.28%
Te Ahumairangi Investment Management Ltd 66,429$9,3371.27%
Caldwell Investment Management Ltd. 11,800$1,643,7641.24%
Willis Investment Counsel 136,800$19,228,6081.24%
Providence Capital Advisors, LLC 34,509$4,850,5851.23%
First Financial Bank - Trust Division 83,931$11,797,3491.23%
TCWP LLC 38,529$5,415,6361.16%
CAUSEWAY CAPITAL MANAGEMENT LLC 308,493$43,361,8281.14%
About QUEST DIAGNOSTICS INC

Quest Diagnostics Inc. is a leading provider of diagnostic information services. The company offers a wide range of services, including clinical laboratory testing, diagnostic imaging, and information technology solutions. Quest Diagnostics operates in the United States, serving patients and healthcare providers across the country.

The company has a strong reputation for quality and accuracy, with a focus on providing timely and reliable results. Quest Diagnostics has a team of highly trained professionals who use the latest technology and techniques to deliver accurate and actionable information to patients and healthcare providers.

Quest Diagnostics has a strong financial position, with a solid balance sheet and a history of consistent growth. The company has a market capitalization of over $15 billion and generates annual revenues of more than $7 billion.

Quest Diagnostics is led by a team of experienced executives, including CEO Steve Rusckowski and CFO Mark Guinan. The company has a strong commitment to innovation and is constantly exploring new ways to improve its services and expand its offerings.

Overall, Quest Diagnostics is a well-respected and successful company that is poised for continued growth and success in the years ahead. With a focus on quality, accuracy, and innovation, Quest Diagnostics is a leader in the diagnostic information services industry and a valuable partner for patients and healthcare providers alike.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists QUEST DIAGNOSTICS INC's shareholders in Q2 2023. To view QUEST DIAGNOSTICS INC's shareholder history, click here.